Anika Therapeutics Inc (ANIK)

EBITDA Margin

2.25%

TTM · Period ending:

ANIK logo

ANIK EBITDA Margin

Latest reported2.25%
ANIK EBITDA Margin (-72.73% → 2.25%)
High-resolution chart · PNG

ANIK ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-3.1715%
4.4676%
14.3826%
16.526%
-2.8168%
-0.7696%
35.1095%
26.2034%
44.1007%
52.5648%
55.8167%
58.1912%
42.6645%
37.5266%
27.7403%
19.5441%
27.8653%
15.8183%
24.0227%
21.652%
30.1994%
54.8855%
10.3934%
-16.524%
-54.605%
1.3123%
8.1336%
24.2687%
29.1667%
-175%
-47.0588%
-25.5319%
-72.7273%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.